1 Min Read
NEW YORK, Jan 9 (Reuters) - Sangamo BioSciences Inc : * Up 13.6 percent to $15.50 in premarket after collaboration deal with Biogen Idec to develop treatments for hemoglobinopathies
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.